Retrieve available abstracts of 78 articles: HTML format
Single Articles
July 2025
BOWDEN SJ, Bodinier B, Paraskevaidi M, Kalliala I, et al DNA methylation signatures of cervical pre-invasive and invasive disease: An
epigenome-wide association study.
Int J Cancer. 2025;157:305-316. PubMedAbstract available
BJORGE T, Stoer NC, Hverven SK, Nygard M, et al Risk of high-grade cervical lesions in the second round of primary human
papillomavirus testing in CervicalScreen Norway: A population-based cohort study.
Int J Cancer. 2025;157:251-259. PubMedAbstract available
CHANDRAN A, Mackie A, Sasieni P, Arbyn M, et al Technical, legal and ethical framework of cancer audit in cervical screening -
Summary of best practices for organised programmes delineated through an expert
group consultation.
Int J Cancer. 2025;157:32-40. PubMedAbstract available
May 2025
GAMA Q, Wang L, Wu P, Liu S, et al Effects of levonorgestrel-releasing intrauterine system on recurrence and
fertility outcomes during assisted reproduction after complete remission of early
endometrioid endometrial cancer and precancerous lesions: A retrospective cohort
study.
Int J Cancer. 2025 May 14. doi: 10.1002/ijc.35465. PubMedAbstract available
April 2025
KALJOUW S, Jansen EEL, Schevenhoven VJC, de Kok IMCM, et al Should the age range of the Dutch hrHPV-based cervical cancer screening program
be broadened? A modelling study using cohort effects.
Int J Cancer. 2025 Apr 28. doi: 10.1002/ijc.35435. PubMedAbstract available
WITJES VM, de Hullu JA, Hermkens DMA, Smolders YHCM, et al Nationwide implementation and evaluation of the Tumor-First workflow for genetic
testing in ovarian carcinoma.
Int J Cancer. 2025 Apr 16. doi: 10.1002/ijc.35440. PubMedAbstract available
GE X, Feng Y, Tan S, Mao W, et al Gestational colorectal cancer: Mechanisms, treatments, and prognosis.
Int J Cancer. 2025 Apr 3. doi: 10.1002/ijc.35425. PubMedAbstract available
COOLEY V, Fortner RT, Mukama T, Naudin S, et al Prospective evaluation of 92 protein biomarkers for early detection of
endometrial cancer.
Int J Cancer. 2025 Apr 3. doi: 10.1002/ijc.35428. PubMedAbstract available
March 2025
ESLAHI M, Pizzato M, Heikkinen S, Martinsen JI, et al Socioeconomic position and risk of cervical cancer in the Nordic countries:
Results from the Nordic Occupational Cancer Study.
Int J Cancer. 2025 Mar 13. doi: 10.1002/ijc.35349. PubMedAbstract available
LI Z, Liu P, Yin A, Zhang B, et al Global landscape of cervical cancer incidence and mortality in 2022 and
predictions to 2030: The urgent need to address inequalities in cervical cancer.
Int J Cancer. 2025 Mar 3. doi: 10.1002/ijc.35369. PubMedAbstract available
WEI W, Zhang Y, Li Y, Huang J, et al Hypoxia-mediated high expression of TRIM15 promotes malignant progression of
high-grade serous ovarian cancer through activation of AKT signaling pathway by
K63 ubiquitination.
Int J Cancer. 2025 Mar 3. doi: 10.1002/ijc.35387. PubMedAbstract available
CHEN Q, Yao X, Quan J, Jia X, et al The variations in the natural history of high-risk human papillomavirus
infections in Chinese healthy women aged 27-45 years compared with 18-26 years: A
prospective cohort study.
Int J Cancer. 2025;156:1043-1054. PubMedAbstract available
February 2025
HAUG AJ, Stoer N, Langseth H, Siafarikas F, et al Non-steroidal anti-inflammatory medication use and endometrial cancer survival: A
population-based Norwegian cohort study.
Int J Cancer. 2025 Feb 24. doi: 10.1002/ijc.35363. PubMedAbstract available
NICHOLS HB, Anderson C, Baggett CD, Cannizzaro NT, et al Pregnancy and pregnancy outcomes after adolescent and young adult cancer in the
AYA horizon study.
Int J Cancer. 2025 Feb 24. doi: 10.1002/ijc.35383. PubMedAbstract available
PEREMIQUEL-TRILLAS P, Martinez JM, Paytubi S, Frias-Gomez J, et al Acceptability and somatic mutations in cervicovaginal self-sampling for early
endometrial cancer detection in women with Lynch syndrome.
Int J Cancer. 2025 Feb 14. doi: 10.1002/ijc.35368. PubMedAbstract available
KEBEDE HB, Mekuria S, Asegid N, Forslund O, et al High-risk human papillomavirus genotypes in previously unscreened
reproductive-age women in Ethiopia: A community-based cohort study.
Int J Cancer. 2025 Feb 14. doi: 10.1002/ijc.35335. PubMedAbstract available
RUNELLO F, Jary A, Duin S, Kim Y, et al DNA methylation and copy number alterations in the progression of HPV-associated
high-grade vulvar intraepithelial lesion.
Int J Cancer. 2025 Feb 12. doi: 10.1002/ijc.35366. PubMedAbstract available
HARPER DM, Paczos T, Ridder R, Huh WK, et al p16/ki-67 dual stain triage of individuals positive for HPV to detect cervical
precancerous lesions.
Int J Cancer. 2025 Feb 4. doi: 10.1002/ijc.35353. PubMedAbstract available
January 2025
LOFLING LL, Stoer NC, Sloan EK, Nafisi S, et al Beta-blockers and epithelial ovarian cancer survival: A Norwegian
population-based cohort study.
Int J Cancer. 2025 Jan 26. doi: 10.1002/ijc.35348. PubMedAbstract available
DU L, Sun H, Tang L, Hao S, et al Cervical cancer incidence rates considering migration status in mainland China
using Bayesian model-Estimation based on 2016 cancer registry data.
Int J Cancer. 2025 Jan 23. doi: 10.1002/ijc.35346. PubMedAbstract available
ARROYO MUHR LS, Wang J, Hassan SS, Yilmaz E, et al Nationwide registry-based trial of risk-stratified cervical screening.
Int J Cancer. 2025;156:379-388. PubMedAbstract available
LUND E, Busund LR, Holden L Curvilinear incidence models for parity in the entire fertility range for cancers
of the breast, ovary, and endometrium: A follow-up of the Norwegian 1960 Census.
Int J Cancer. 2025 Jan 3. doi: 10.1002/ijc.35312. PubMedAbstract available
December 2024
VERROU E, Koutoukoglou P, Kontana E, Gogolopoulos S, et al Incidence, characteristics and outcome of therapy-related myeloid neoplasms in
women with epithelial ovarian cancer after exposure to poly-ADPribose polymerase
inhibitors: A cancer center experience.
Int J Cancer. 2024 Dec 17. doi: 10.1002/ijc.35299. PubMedAbstract available
VERHOEF L, Bleeker MCG, Polman N, Kroon KR, et al Colposcopy referrals and CIN3 detection after triage by host cell DNA methylation
and/or HPV genotyping in HPV positive women with low-grade cytology from a
population-based Dutch primary HPV screening trial.
Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35289. PubMedAbstract available
HUNG FH, Peng HP, Hung CF, Hsieh LL, et al Performance evaluation of predictive models for detecting MMR gene mutations
associated with Lynch syndrome in cancer patients in a Chinese cohort in Taiwan.
Int J Cancer. 2024;155:2201-2210. PubMedAbstract available
KEN-AMOAH S, Redl E, Domson BKS, Barrett JE, et al Performance of the WID-qEC test to detect uterine cancers in black women with
abnormal uterine bleeding: A prospective observational cohort study in Ghana.
Int J Cancer. 2024 Dec 10. doi: 10.1002/ijc.35260. PubMedAbstract available
TUNG HJ, Wang YC, Lin CY, Liao MJ, et al Human papillomavirus prevalence, genotype distribution, and prognostic factors of
vaginal cancer.
Int J Cancer. 2024;155:1996-2008. PubMedAbstract available
November 2024
PEDERSEN BT, Sonne SB, Pedersen H, Andreasen EK, et al Participation and relative cost of attendance by direct-mail compared to opt-in
invitation strategy for HPV self-sampling targeting cervical screening
non-attenders: A large-scale, randomized, pragmatic study.
Int J Cancer. 2024 Nov 23. doi: 10.1002/ijc.35263. PubMedAbstract available
LIU H, Zou M, Shen M, Kamarulzaman A, et al HPV vaccination is highly effective and cost-effective for cervical cancer
prevention in women living with HIV in China: A cost-effectiveness analysis.
Int J Cancer. 2024 Nov 17. doi: 10.1002/ijc.35242. PubMedAbstract available
JENSEN A, Guleria S, Albieri V, Nohr B, et al Fertility treatment and risk of ovarian cancer in a large nationwide cohort of
infertile Danish women.
Int J Cancer. 2024 Nov 14. doi: 10.1002/ijc.35251. PubMedAbstract available
BONAVENTURE A, Simpson J, Kane E, Roman E, et al Maternal illnesses during pregnancy and the risk of childhood cancer: A
medical-record based analysis (UKCCS).
Int J Cancer. 2024 Nov 13. doi: 10.1002/ijc.35166. PubMedAbstract available
WATLING CZ, Kelly RK, Watts EL, Graubard BI, et al Total testosterone, sex hormone-binding globulin, and free testosterone
concentrations and risk of primary liver cancer: A prospective analysis of
200,000 men and 180,000 postmenopausal women.
Int J Cancer. 2024 Nov 5. doi: 10.1002/ijc.35244. PubMedAbstract available
SCHAAFSMA M, Schuurman TN, Kootstra P, Issa D, et al Nationwide cohort study on the risk of high-grade cervical dysplasia and
carcinoma after conservative treatment or hysterectomy for adenocarcinoma in
situ.
Int J Cancer. 2024 Nov 4. doi: 10.1002/ijc.35237. PubMedAbstract available
SCHEI-ANDERSEN AJ, Hendricks LAJ, van der Post RS, Mensenkamp AR, et al Histopathological phenotyping of cancers in PTEN Hamartoma Tumor Syndrome for
improved recognition: A single-center study.
Int J Cancer. 2024;155:1567-1576. PubMedAbstract available
LOUVANTO K, Verhoef L, Pimenoff V, Eriksson T, et al Low methylation marker levels among human papillomavirus-vaccinated women with
cervical high-grade squamous intraepithelial lesions.
Int J Cancer. 2024;155:1549-1557. PubMedAbstract available
October 2024
DESCAMPS P, Bosch Jose FX, Monsonego J, Neisingh O, et al Cervical cancer screening: Sharing best practices and addressing common
challenges in cervical cancer screening programs.
Int J Cancer. 2024 Oct 26. doi: 10.1002/ijc.35220. PubMed
LEHTINEN M, Elfstrom M, Vanska S, Dillner J, et al Elimination of cervical cancer by refined vaccination and screening.
Int J Cancer. 2024 Oct 25. doi: 10.1002/ijc.35228. PubMed
KOKEMULLER L, Ramachandran D, Schurmann P, Geffers R, et al Germline variants of homology-directed repair or mismatch repair genes in
cervical cancer.
Int J Cancer. 2024 Oct 23. doi: 10.1002/ijc.35221. PubMedAbstract available
BIGNOTTI E, Simeon V, Ardighieri L, Kuhn E, et al TP53 mutations and survival in ovarian carcinoma patients receiving first-line
chemotherapy plus bevacizumab: Results of the MITO16A/MaNGO OV-2 study.
Int J Cancer. 2024 Oct 16. doi: 10.1002/ijc.35203. PubMedAbstract available
MISHRA GA, Pimple SA, Anand KV, Kulkarni VY, et al Acceptability and validity of HPV self-sampling for cervical cancer screening
among women living in different ecological settings in India.
Int J Cancer. 2024 Oct 16. doi: 10.1002/ijc.35222. PubMedAbstract available
ZHENG Y, Vdovichenko N, Schurmann P, Ramachandran D, et al Comparative sequencing study of mismatch repair and homology-directed repair
genes in endometrial cancer and breast cancer patients from Kazakhstan.
Int J Cancer. 2024 Oct 14. doi: 10.1002/ijc.35215. PubMedAbstract available
CUI M, Song L, Mao R, Lyu Y, et al Exposure to polycyclic aromatic hydrocarbons promotes the progression of
low-grade cervical intraepithelial neoplasia: A population-based cohort study in
China.
Int J Cancer. 2024;155:1162-1171. PubMedAbstract available
September 2024
CHEN J, Shi J, Cao Y, Li C, et al A new treatment approach of toripalimab in combination with concurrent
platinum-based chemoradiotherapy for locally advanced cervical cancer: A phase II
clinical trial.
Int J Cancer. 2024 Sep 28. doi: 10.1002/ijc.35206. PubMedAbstract available
JONSSON S, Jonsson H, Lundin E, Haggstrom C, et al Pelvic inflammatory disease and risk of borderline ovarian tumors: A national
population-based case-control study in Sweden.
Int J Cancer. 2024 Sep 25. doi: 10.1002/ijc.35180. PubMedAbstract available
DEBEAUDRAP P, Kabore FN, Setha L, Tegbe J, et al Performance of visual inspection, partial genotyping, and their combination for
the triage of women living with HIV who are screen positive for human
papillomavirus: Results from the AIMA-CC ANRS 12375 multicentric screening study.
Int J Cancer. 2024 Sep 25. doi: 10.1002/ijc.35190. PubMedAbstract available
OSTRBENK VALENCAK A, Kroon KR, Fabjan D, Mlakar J, et al Clinically validated HPV assays offer comparable long-term safety in primary
cervical cancer screening: A 9-year follow-up of a population-based screening
cohort.
Int J Cancer. 2024 Sep 24. doi: 10.1002/ijc.35200. PubMedAbstract available
NA R, Jordan SJ, DeFazio A, Williams M, et al Use of menopausal hormone therapy before and after diagnosis and ovarian cancer
survival-A prospective cohort study in Australia.
Int J Cancer. 2024 Sep 2. doi: 10.1002/ijc.35154. PubMedAbstract available
FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al Effectiveness of self-sampling human papillomavirus test on precancer detection
and screening uptake in Japan: The ACCESS randomized controlled trial.
Int J Cancer. 2024;155:905-915. PubMedAbstract available
August 2024
VLEDDER A, Paijens ST, Loiero D, Maagdenberg A, et al B cells critical for outcome in high grade serous ovarian carcinoma.
Int J Cancer. 2024 Aug 22. doi: 10.1002/ijc.35149. PubMedAbstract available
SCHAAFSMA M, van den Helder R, Mom CH, Steenbergen RDM, et al Recurrent cervical cancer detection using DNA methylation markers in
self-collected samples from home.
Int J Cancer. 2024 Aug 22. doi: 10.1002/ijc.35143. PubMedAbstract available
July 2024
Expression of Concern: miR-145 sensitizes ovarian cancer cells to paclitaxel by
targeting Sp1 and Cdk6.
Int J Cancer. 2024 Jul 31. doi: 10.1002/ijc.35121. PubMed
KADERLY RASMUSSEN EL, Hannibal CG, Hertzum-Larsen R, Kjaer SK, et al Biopsy-verified vulvar lichen sclerosus and the risk of non-vulvar cancer: A
nationwide cohort study.
Int J Cancer. 2024 Jul 17. doi: 10.1002/ijc.35101. PubMedAbstract available
LYNGE E, Bennekou Schroll J, Andersen B, Balasubramaniam K, et al Cervical cancer incidence in Denmark: Disentangling determinants of time trend.
Int J Cancer. 2024 Jul 14. doi: 10.1002/ijc.35081. PubMedAbstract available
MORO F, Ciancia M, Zace D, Vagni M, et al Role of artificial intelligence applied to ultrasound in gynecology oncology: A
systematic review.
Int J Cancer. 2024 Jul 11. doi: 10.1002/ijc.35092. PubMedAbstract available
GILHAM C, Nedjai B, Scibior-Bentkowska D, Reuter C, et al Long-term prediction by DNA methylation of high-grade cervical intraepithelial
neoplasia: Results of the ARTISTIC cohort.
Int J Cancer. 2024;155:81-92. PubMedAbstract available
June 2024
Correction to "Paclitaxel and ceramide co-administration in biodegradable
polymeric nanoparticulate delivery system to overcome drug resistance in ovarian
cancer".
Int J Cancer. 2024 Jun 21. doi: 10.1002/ijc.35059. PubMed
ALHARBI M, Lai A, Godbole N, Guanzon D, et al Enhancing precision targeting of ovarian cancer tumor cells in vivo through
extracellular vesicle engineering.
Int J Cancer. 2024 Jun 7. doi: 10.1002/ijc.35055. PubMedAbstract available
May 2024
LOBIN C, Orang'o EO, Were E, Muthoka K, et al Cost-effectiveness analysis of alternative screening strategies for the detection
of cervical cancer among women in rural areas of Western Kenya.
Int J Cancer. 2024 May 27. doi: 10.1002/ijc.35036. PubMedAbstract available
CHAO X, Kai Z, Wu H, Wang J, et al Fragmentomics features of ovarian cancer.
Int J Cancer. 2024 May 20. doi: 10.1002/ijc.34981. PubMedAbstract available
HANSEN BT, Nygard M, Castle PE, Burger EA, et al Sociodemographic characteristics associated with cervical cancer screening
participation by send-to-all and opt-in HPV self-sampling: Who benefits? Results
from a randomized controlled trial among long-term non-attending women in Norway.
Int J Cancer. 2024 May 15. doi: 10.1002/ijc.34989. PubMedAbstract available
ILLAH O, Scott M, Redl E, Barrett JE, et al High performance of the DNA methylation-based WID-qEC test for detecting uterine
cancers independent of sampling modalities.
Int J Cancer. 2024 May 13. doi: 10.1002/ijc.35000. PubMedAbstract available
ROSTAMI S, Rounge TB, Pestarino L, Lyle R, et al Differential levels of circulating RNAs prior to endometrial cancer diagnosis.
Int J Cancer. 2024 May 11. doi: 10.1002/ijc.34951. PubMedAbstract available
HUANG C, Bu H, Wang Y, Chu R, et al Association between coffee and tea consumption and ovarian cancer incidence: A
prospective analysis in the PLCO dataset.
Int J Cancer. 2024 May 11. doi: 10.1002/ijc.34982. PubMedAbstract available
TAGUCHI A, Kato K, Furusawa A, Hara K, et al Heterogeneous treatment effect of dose-dense paclitaxel plus carboplatin therapy
for advanced ovarian cancer.
Int J Cancer. 2024 May 7. doi: 10.1002/ijc.34996. PubMedAbstract available
FROMHAGE G, Obermayr E, Bednarz-Knoll N, Van Gorp T, et al Loss of copy numbers of retrotransposons (HERVK) on chromosome 7p11.2 impacts
EGFR (Epidermal Growth Factor Receptor)-induced phenotypes for platinum
sensitivity and long-term survival in ovarian cancer-A study from the OVCAD
consortium.
Int J Cancer. 2024 May 6. doi: 10.1002/ijc.34976. PubMedAbstract available
KITAHARA CM, Surcel HM, Falk R, Pfeiffer RM, et al Early-pregnancy sex steroid and thyroid function hormones, thyroid autoimmunity,
and maternal papillary thyroid cancer incidence in the Finnish Maternity Cohort.
Int J Cancer. 2024 May 2. doi: 10.1002/ijc.34974. PubMedAbstract available
April 2024
OBERMAYR E, Mohr T, Schuster E, Braicu EI, et al Gene expression markers in peripheral blood and outcome in patients with
platinum-resistant ovarian cancer: A study of the European GANNET53 consortium.
Int J Cancer. 2024 Apr 27. doi: 10.1002/ijc.34978. PubMedAbstract available
BUDUKH A, Dora T, Sancheti S, Singh V, et al Outcome of early detection approach in control of breast, cervical, and oral
cancer: Experience from a rural cancer center in India.
Int J Cancer. 2024 Apr 20. doi: 10.1002/ijc.34966. PubMedAbstract available
DOWNHAM L, Rol ML, Forestier M, Romero P, et al Field experience with the 8-HPV-type oncoprotein test for cervical cancer
screening among HPV-positive women living with and without HIV in LMICs.
Int J Cancer. 2024 Apr 11. doi: 10.1002/ijc.34953. PubMedAbstract available
SINGINI MG, Muchengeti M, Sitas F, Chen WC, et al Antibodies against high-risk human papillomavirus proteins as markers for
noncervical HPV-related cancers in a Black South African population, according to
HIV status.
Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34919. PubMedAbstract available
March 2024
DUUS AH, Hannibal CG, Baandrup L, Zheng G, et al Prediagnostic use of menopausal hormone therapy and long-term survival of
localized epithelial ovarian cancer: The Extreme study.
Int J Cancer. 2024 Mar 26. doi: 10.1002/ijc.34936. PubMedAbstract available
BAANDRUP L, Hannibal CG, Hertzum-Larsen R, Kjaer SK, et al Biopsy-verified vulvar lichen sclerosus: Incidence trends 1997-2022 and increased
risk of vulvar squamous precancer and squamous cell carcinoma.
Int J Cancer. 2024 Mar 22. doi: 10.1002/ijc.34927. PubMedAbstract available
LI N, Yi H, Sun W, Sundquist J, et al Revealing genes associated with cervical cancer in distinct immune cells: A
comprehensive Mendelian randomization analysis.
Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34911. PubMedAbstract available
HOLY P, Hlavac V, Seborova K, Susova S, et al Targeted DNA sequencing of high-grade serous ovarian carcinoma reveals
association of TP53 mutations with platinum resistance when combined with gene
expression.
Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34908. PubMedAbstract available
STERPETTI AV, Gabriele R, Iannone I, Sapienza P, et al Reduced adherence to cervical cancer screening. The importance of information and
education for women with low education and low-income.
Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34907. PubMed
OLTHOF EMG, Aitken CA, Siebers AG, van Kemenade FJ, et al The impact of loss to follow-up in the Dutch organised HPV-based cervical cancer
screening programme.
Int J Cancer. 2024 Mar 4. doi: 10.1002/ijc.34902. PubMedAbstract available
February 2024
LINDQUIST S, Frederiksen K, Petersen LK, Kjaer SK, et al The risk of vaginal, vulvar and anal precancer and cancer according to high-risk
HPV status in cervical cytology samples.
Int J Cancer. 2024 Feb 28. doi: 10.1002/ijc.34896. PubMedAbstract available
WEN TM, Xu XQ, Zhao XL, Pan CH, et al Efficacy and immunogenicity of AS04-HPV-16/18 vaccine in females with existing
cervical HR-HPV infection at first vaccination: A pooled analysis of four large
clinical trials worldwide.
Int J Cancer. 2024 Feb 17. doi: 10.1002/ijc.34882. PubMedAbstract available